Jo Salkeld

National Institute for Health and Care Research

Also affiliated with University of Oxford, Kavli Energy NanoScience Institute

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial”.

Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial

The Lancet Infectious Diseases(2024)10.1016/s1473-3099(24)00312-8

N/A

1.3DataRank · unranked

45 citations

Wilmina F. Kalinga, Jo Salkeld, Ivanny M. Mtaka, Saumu Ahmed, Florence A. Milando +38 more

Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection

Science Translational Medicine(2023)10.1126/scitranslmed.adf1782

N/A

0DataRank · unranked

40 citations

Jordan R. Barrett, Yrene Themistocleous, Thomas A. Rawlinson, Ababacar Diouf, Francisco José Martínez Martínez +31 more